ciprofloxacin has been researched along with Francisella tularensis Infection in 63 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The efficacies of gatifloxacin and moxifloxacin were assessed in a BALB/c mouse model of pneumonic tularemia and compared with the efficacy of ciprofloxacin." | 7.73 | Treatment of murine pneumonic Francisella tularensis infection with gatifloxacin, moxifloxacin or ciprofloxacin. ( Brooks, TJ; Lever, MS; Piercy, T; Simpson, AJ; Steward, J, 2006) |
| "The effect of liposome delivery on the controlled release and therapeutic efficacy of ciprofloxacin against intracellular Francisella tularensis infection in vivo was evaluated in this study." | 7.72 | Liposome delivery of ciprofloxacin against intracellular Francisella tularensis infection. ( Blasetti, KL; Conley, J; Schnell, G; Schofield, LN; Wong, JP; Yang, H, 2003) |
| "In 12 patients (median age, 4 years; range, 1 to 10) with ulceroglandular tularemia, a 10- to 14-day course of oral ciprofloxacin, 15 to 20 mg/kg daily in 2 divided doses, was prescribed." | 7.70 | Ciprofloxacin for treatment of tularemia in children. ( Berglund, L; Gothefors, L; Johansson, A; Sjöstedt, A; Tärnvik, A, 2000) |
| "We describe a patient with ulceroglandular tularemia who initially responded to therapy with gentamicin but then clinically relapsed." | 4.79 | Relapse of tularemia after aminoglycoside therapy: case report and discussion of therapeutic options. ( Pombo, DJ; Risi, GF, 1995) |
| " A diagnosis of tularemia was made serologically, but treatment with ciprofloxacin initially failed." | 3.91 | Clinical characteristics in a sentinel case as well as in a cluster of tularemia patients associated with grape harvest. ( Grunow, R; Hogardt, M; Jacob, D; Jozsa, K; Just-Nübling, G; Kann, G; Kärcher, I; Küpper-Tetzel, CP; Wetzstein, N; Wolf, T, 2019) |
| "The efficacies of gatifloxacin and moxifloxacin were assessed in a BALB/c mouse model of pneumonic tularemia and compared with the efficacy of ciprofloxacin." | 3.73 | Treatment of murine pneumonic Francisella tularensis infection with gatifloxacin, moxifloxacin or ciprofloxacin. ( Brooks, TJ; Lever, MS; Piercy, T; Simpson, AJ; Steward, J, 2006) |
| "The effect of liposome delivery on the controlled release and therapeutic efficacy of ciprofloxacin against intracellular Francisella tularensis infection in vivo was evaluated in this study." | 3.72 | Liposome delivery of ciprofloxacin against intracellular Francisella tularensis infection. ( Blasetti, KL; Conley, J; Schnell, G; Schofield, LN; Wong, JP; Yang, H, 2003) |
| "In 12 patients (median age, 4 years; range, 1 to 10) with ulceroglandular tularemia, a 10- to 14-day course of oral ciprofloxacin, 15 to 20 mg/kg daily in 2 divided doses, was prescribed." | 3.70 | Ciprofloxacin for treatment of tularemia in children. ( Berglund, L; Gothefors, L; Johansson, A; Sjöstedt, A; Tärnvik, A, 2000) |
| " The intraocular pressure, which was 68 mmHg at the beginning was lowered with intravenous and per oral acetatcolamide together with timolol and pilocarpine eyedrops, and because of a narrow anterior chamber, with subsequent laser iridotomies." | 3.69 | Acute glaucoma and acute corneal oedema in association with tularemia. ( Pärssinen, O; Rummukainen, M, 1997) |
| "Tularemia is a zoonotic disease caused by Francisella tularensis." | 2.45 | Tularemic meningitis in the United States. ( Cardona, L; Davis, LE; Hofinger, DM; Mertz, GJ, 2009) |
| "Tularemia is a zoonosis transmitted either directly from infected animals or indirectly via tick or mosquito bites, inhalation of contaminated dust or ingestion of contaminated water." | 1.51 | [Mediastinal Lymphadenopathy - Tuberculosis or Tularemia?] ( Geerdes-Fenge, HF; Löbermann, M; Reisinger, EC; Warnke, P; Zimpfer, A, 2019) |
| " Ciprofloxacin dosed in identical fashion displayed rapid clearance with a half-life of approximately 30 min." | 1.48 | Macrophage-targeted drugamers with enzyme-cleavable linkers deliver high intracellular drug dosing and sustained drug pharmacokinetics against alveolar pulmonary infections. ( Chen, J; Convertine, AJ; Lee, B; Ratner, DM; Skerrett, SJ; Srinivasan, S; Stayton, PS; Su, FY; West, TE, 2018) |
| "Oculoglandular tularemia is not only suspected in cases who complain of fever, cervical lymphadenopathy and purulent conjunctivitis, it should also be suspected in cases who are admitted to the hospital with acute dacryocystitis, which is a rare component of oculoglandular syndrome." | 1.39 | Unilateral acute dacryocystitis associated with oculoglandular tularemia: a case report. ( Celik, T; Kosker, M; Turkoglu, EB; Yuksel, D, 2013) |
| "Ciprofloxacin is an effective and convenient choice in epidemics of tularemia and early treatment is still the cornerstone of successful therapies." | 1.39 | Tularemia in central Anatolia. ( Gulen, G; Kilic, S; Sencan, I; Sezen, F; Ulu-Kilic, A, 2013) |
| "Tularemia is a worldwide zoonosis caused by Francisella tularensis." | 1.38 | Cavitary pneumonia and skin lesions. ( Alvela-Suárez, L; Belhassen-Garcia, M; Carpio-Pérez, A; Fraile-Alonso, Mdel C; Pardo-Lledias, J; Velasco-Tirado, V, 2012) |
| "Tularemia is frequently initially misdiagnosed." | 1.38 | Clinical recognition and management of tularemia in Missouri: a retrospective records review of 121 cases. ( Griffith, KS; Kugeler, KJ; Mead, PS; Patrick, S; Turabelidze, G; Weber, IB, 2012) |
| "The biopsy showed necrotic lymphadenitis." | 1.36 | [Rabbit fever--a neck tumor]. ( Høstmark, K; Moritz, J, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (15.87) | 18.2507 |
| 2000's | 18 (28.57) | 29.6817 |
| 2010's | 29 (46.03) | 24.3611 |
| 2020's | 6 (9.52) | 2.80 |
| Authors | Studies |
|---|---|
| Urich, SK | 1 |
| Petersen, JM | 1 |
| Mäki-Koivisto, V | 1 |
| Korkala, M | 1 |
| Simola, L | 1 |
| Suutari-Kontio, S | 1 |
| Koivunen, S | 1 |
| Puhto, T | 1 |
| Junttila, IS | 1 |
| Geerdes-Fenge, HF | 1 |
| Löbermann, M | 1 |
| Warnke, P | 1 |
| Zimpfer, A | 1 |
| Reisinger, EC | 1 |
| Haulrig, MB | 1 |
| Mathiasen, G | 1 |
| Nielsen, RM | 1 |
| Kromann, CB | 1 |
| Krogfelt, KA | 1 |
| Wiese, L | 1 |
| Chevalier, K | 1 |
| Venon, MD | 1 |
| Émile, JF | 1 |
| Cabral, D | 1 |
| Siméon, S | 1 |
| Trichet, M | 1 |
| Rouveix, É | 1 |
| Hanslik, T | 1 |
| Coutte, L | 1 |
| Antonitsch, L | 1 |
| Weidinger, G | 1 |
| Stanek, G | 1 |
| Markowicz, M | 1 |
| Sutera, V | 1 |
| Hennebique, A | 2 |
| Lopez, F | 1 |
| Fernandez, N | 1 |
| Schneider, D | 1 |
| Maurin, M | 3 |
| Roth, S | 1 |
| Thurner, L | 1 |
| Becker, SL | 1 |
| Chance, T | 1 |
| Chua, J | 1 |
| Toothman, RG | 1 |
| Ladner, JT | 1 |
| Nuss, JE | 1 |
| Raymond, JL | 1 |
| Biot, FV | 1 |
| Demons, S | 1 |
| Miller, L | 1 |
| Halasohoris, S | 1 |
| Mou, S | 1 |
| Koroleva, G | 1 |
| Lovett, S | 1 |
| Palacios, G | 1 |
| Vietri, NJ | 1 |
| Worsham, PL | 1 |
| Cote, CK | 1 |
| Kijek, TM | 1 |
| Bozue, JA | 1 |
| Calin, R | 1 |
| Caumes, E | 1 |
| Reibel, F | 1 |
| Ali Mohamed, A | 1 |
| Brossier, F | 1 |
| Foltz, V | 1 |
| Boussouar, S | 1 |
| Fautrel, B | 1 |
| Katlama, C | 1 |
| Pourcher, V | 1 |
| Tomaso, H | 1 |
| Hotzel, H | 1 |
| Otto, P | 1 |
| Myrtennäs, K | 1 |
| Forsman, M | 1 |
| Caspar, Y | 1 |
| Drago, F | 1 |
| Javor, S | 1 |
| Parodi, A | 1 |
| Su, FY | 1 |
| Srinivasan, S | 1 |
| Lee, B | 1 |
| Chen, J | 1 |
| Convertine, AJ | 1 |
| West, TE | 1 |
| Ratner, DM | 1 |
| Skerrett, SJ | 2 |
| Stayton, PS | 1 |
| Martín Guerra, JM | 1 |
| Martín Asenjo, M | 1 |
| Prieto de Paula, JM | 1 |
| Taubenslag, KJ | 1 |
| Michaels, MG | 1 |
| Sylvester, CL | 1 |
| Wetzstein, N | 1 |
| Kärcher, I | 1 |
| Küpper-Tetzel, CP | 1 |
| Kann, G | 1 |
| Hogardt, M | 1 |
| Jozsa, K | 1 |
| Jacob, D | 1 |
| Grunow, R | 2 |
| Just-Nübling, G | 1 |
| Wolf, T | 1 |
| Celik, T | 1 |
| Yuksel, D | 1 |
| Kosker, M | 1 |
| Turkoglu, EB | 1 |
| Bloch, C | 1 |
| Friedl, A | 2 |
| Zucol, F | 1 |
| Widmer, A | 1 |
| Khanna, N | 1 |
| Stundick, MV | 1 |
| Albrecht, MT | 1 |
| Houchens, CR | 1 |
| Smith, AP | 1 |
| Dreier, TM | 1 |
| Larsen, JC | 1 |
| Hamblin, KA | 2 |
| Armstrong, SJ | 1 |
| Barnes, KB | 1 |
| Davies, C | 1 |
| Wong, JP | 5 |
| Blanchard, JD | 2 |
| Harding, SV | 1 |
| Simpson, AJ | 2 |
| Atkins, HS | 2 |
| Rimawi, RH | 1 |
| Shah, KB | 1 |
| Chowdhary, RA | 1 |
| Cook, PP | 1 |
| Marquart, JD | 1 |
| Clifford, R | 1 |
| James, J | 1 |
| Kaul, DR | 1 |
| Goldberger, ZD | 1 |
| Saint, S | 1 |
| Foster, CL | 1 |
| Badlam, J | 1 |
| De Groote, MA | 1 |
| Chan, ED | 1 |
| Hofinger, DM | 1 |
| Cardona, L | 1 |
| Mertz, GJ | 1 |
| Davis, LE | 1 |
| Lübbert, C | 1 |
| Taege, C | 1 |
| Seufferlein, T | 1 |
| Høstmark, K | 1 |
| Moritz, J | 1 |
| Scheftel, JM | 1 |
| Griffith, JM | 1 |
| Leppke, BA | 1 |
| Pantlin, GC | 1 |
| Snippes, PM | 1 |
| Wünschmann, A | 1 |
| Alsan, MM | 1 |
| Lin, HW | 1 |
| Faucon, AL | 1 |
| Zamfir, O | 1 |
| Dupouët, L | 1 |
| Pruna, A | 1 |
| Belhassen-Garcia, M | 1 |
| Velasco-Tirado, V | 1 |
| Alvela-Suárez, L | 1 |
| Fraile-Alonso, Mdel C | 1 |
| Carpio-Pérez, A | 1 |
| Pardo-Lledias, J | 1 |
| Rotem, S | 1 |
| Bar-Haim, E | 1 |
| Cohen, H | 1 |
| Elia, U | 1 |
| Ber, R | 1 |
| Shafferman, A | 1 |
| Cohen, O | 1 |
| Weber, IB | 1 |
| Turabelidze, G | 1 |
| Patrick, S | 1 |
| Griffith, KS | 1 |
| Kugeler, KJ | 1 |
| Mead, PS | 1 |
| Portero, A | 1 |
| Careño, E | 1 |
| Real, LA | 1 |
| Villarón, S | 1 |
| Herreras, JM | 1 |
| Ulu-Kilic, A | 1 |
| Gulen, G | 1 |
| Sezen, F | 1 |
| Kilic, S | 2 |
| Sencan, I | 2 |
| Ulu Kılıç, A | 1 |
| Celebi, B | 1 |
| Atlas, RM | 1 |
| Stupak, HD | 1 |
| Scheuller, MC | 1 |
| Schindler, DN | 1 |
| Ellison, DE | 1 |
| Yang, H | 2 |
| Blasetti, KL | 1 |
| Schnell, G | 2 |
| Conley, J | 2 |
| Schofield, LN | 1 |
| Heinzer, I | 1 |
| Fankhauser, H | 1 |
| Piercy, T | 2 |
| Steward, J | 2 |
| Lever, MS | 2 |
| Brooks, TJ | 2 |
| Celebi, G | 1 |
| Baruönü, F | 1 |
| Ayoğlu, F | 1 |
| Cinar, F | 1 |
| Karadenizli, A | 1 |
| Uğur, MB | 1 |
| Gedikoğlu, S | 1 |
| Charles, P | 1 |
| Stumpf, P | 1 |
| Buffet, P | 1 |
| Hot, A | 1 |
| Lecuit, M | 1 |
| Dupont, B | 1 |
| Lortholary, O | 1 |
| Consigny, PH | 1 |
| Risi, GF | 1 |
| Pombo, DJ | 1 |
| Di Ninno, VL | 1 |
| Cherwanogrodzky, JW | 1 |
| Wilson, T | 1 |
| Blasetti, K | 1 |
| Di Ninno, V | 1 |
| Pärssinen, O | 1 |
| Rummukainen, M | 1 |
| Russell, P | 1 |
| Eley, SM | 1 |
| Fulop, MJ | 1 |
| Bell, DL | 1 |
| Titball, RW | 1 |
| Berglund, L | 3 |
| Gothefors, L | 2 |
| Tärnvik, A | 3 |
| Naughton, M | 1 |
| Brown, R | 1 |
| Adkins, D | 1 |
| DiPersio, J | 1 |
| Hakola, K | 1 |
| Savola, J | 1 |
| Johansson, A | 2 |
| Sjöstedt, A | 2 |
| Arav-Boger, R | 1 |
| D'iakov, SI | 1 |
| Bubnov, VP | 1 |
| Lebedeva, IK | 1 |
| Sidorenko, SV | 1 |
| Moskalenko, VI | 1 |
| Chocarro, A | 1 |
| Gonzalez, A | 1 |
| Garcia, I | 1 |
| Persell, DJ | 1 |
| Arangie, P | 1 |
| Young, C | 1 |
| Stokes, EN | 1 |
| Payne, WC | 1 |
| Skorga, P | 1 |
| Gilbert-Palmer, D | 1 |
| Luotonen, L | 1 |
| Tapiainen, T | 1 |
| Kallioinen, M | 1 |
| Luotonen, J | 1 |
| Scheel, O | 1 |
| Reiersen, R | 1 |
| Hoel, T | 1 |
| Syrjälä, H | 1 |
| Schildt, R | 1 |
| Räisäinen, S | 1 |
8 reviews available for ciprofloxacin and Francisella tularensis Infection
| Article | Year |
|---|---|
Animal models for Francisella tularensis and Burkholderia species: scientific and regulatory gaps toward approval of antibiotics under the FDA Animal Rule.
Topics: Animals; Anti-Bacterial Agents; Burkholderia; Burkholderia Infections; Ciprofloxacin; Disease Models | 2013 |
Hunting for tularaemia - a review of cases in North Carolina.
Topics: Animals; Anti-Bacterial Agents; Bites and Stings; Cats; Ciprofloxacin; Francisella tularensis; Human | 2015 |
The potential of liposome-encapsulated ciprofloxacin as a tularemia therapy.
Topics: Administration, Inhalation; Administration, Intranasal; Animals; Anti-Bacterial Agents; Ciprofloxaci | 2014 |
Tularemic meningitis in the United States.
Topics: Administration, Oral; Adult; Chloramphenicol; Ciprofloxacin; Diagnosis, Differential; Drug Therapy, | 2009 |
[Prolonged course of tick-borne ulceroglandular tularemia in a 20-year-old patient in Germany--case report and review of the literature].
Topics: Anti-Bacterial Agents; Antibodies, Bacterial; Axilla; Ciprofloxacin; Diagnosis, Differential; Doxycy | 2009 |
Bioterriorism: from threat to reality.
Topics: Animals; Anthrax; Bacterial Infections; Bioterrorism; Botulism; Cattle; Ciprofloxacin; Humans; Plagu | 2002 |
Relapse of tularemia after aminoglycoside therapy: case report and discussion of therapeutic options.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Female; Gentamicins; Humans; Recurrence; Tularemia | 1995 |
Preparing for bioterrorism: category A agents.
Topics: Anthrax; Anti-Bacterial Agents; Anti-Infective Agents; Bioterrorism; Botulism; Ciprofloxacin; Humans | 2001 |
55 other studies available for ciprofloxacin and Francisella tularensis Infection
| Article | Year |
|---|---|
In vitro susceptibility of isolates of Francisella tularensis types A and B from North America.
Topics: Anti-Bacterial Agents; Francisella tularensis; Humans; Microbial Sensitivity Tests; North America; T | 2008 |
Positive Francisella tularensis meningitis outcome despite delayed identification: a case report.
Topics: Ciprofloxacin; Female; Francisella tularensis; Humans; Meningitis; Polymerase Chain Reaction; Tulare | 2023 |
[Mediastinal Lymphadenopathy - Tuberculosis or Tularemia?]
Topics: Aged; Anti-Bacterial Agents; Ciprofloxacin; Diagnosis, Differential; Humans; Lymphadenopathy; Male; | 2019 |
Two cases of tick-borne transmitted tularemia on Southern Zealand, Denmark.
Topics: Aged; Animals; Anti-Bacterial Agents; Ciprofloxacin; Denmark; Doxycycline; Female; Francisella tular | 2020 |
[A tularemia mimicking lymphoma].
Topics: Anti-Bacterial Agents; Ciprofloxacin; Diagnosis, Differential; Female; Granuloma; Humans; Lymphadeni | 2020 |
Francisella tularensis as the cause of protracted fever.
Topics: Abdominal Pain; Anti-Bacterial Agents; Body Weight; Ceftriaxone; Ciprofloxacin; Cough; Diagnosis, Di | 2020 |
Genomic trajectories to fluoroquinolone resistance in Francisella tularensis subsp. holarctica live vaccine strain.
Topics: Anti-Bacterial Agents; Biological Transport; Carrier Proteins; Ciprofloxacin; DNA Topoisomerases; Dr | 2020 |
Application of the FilmArray® BioThreat Panel for molecular diagnosis of human tularemia.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Female; Francisella tularensis; Humans; Molecular Diagn | 2021 |
A spontaneous mutation in kdsD, a biosynthesis gene for 3 Deoxy-D-manno-Octulosonic Acid, occurred in a ciprofloxacin resistant strain of Francisella tularensis and caused a high level of attenuation in murine models of tularemia.
Topics: Animals; Bacterial Proteins; Ciprofloxacin; Drug Resistance, Bacterial; Francisella tularensis; Lipo | 2017 |
Severe glandular tularemia in a patient treated with anti-tumour necrosis factor for psoriatic arthritis.
Topics: Adalimumab; Adult; Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antirheumatic Agents; Art | 2017 |
Antibiotic susceptibility in vitro of Francisella tularensis subsp. holarctica isolates from Germany.
Topics: Animals; Animals, Wild; Anti-Bacterial Agents; Ciprofloxacin; Doxycycline; Foxes; Francisella tulare | 2017 |
Antibiotic susceptibility of Francisella tularensis subsp. holarctica strains isolated from tularaemia patients in France between 2006 and 2016.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Doxycycline; Drug Resistance, Multiple, Bacterial; France; Fra | 2018 |
Case Report: Atypical Cutaneous Manifestations of Tularemia after Horsefly Bite.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Antibodies, Bacterial | 2018 |
Macrophage-targeted drugamers with enzyme-cleavable linkers deliver high intracellular drug dosing and sustained drug pharmacokinetics against alveolar pulmonary infections.
Topics: Administration, Inhalation; Animals; Anti-Bacterial Agents; Ciprofloxacin; Delayed-Action Preparatio | 2018 |
Adenopathy in a hunting fan.
Topics: Aged; Animals; Anti-Bacterial Agents; Axilla; Ciprofloxacin; Francisella tularensis; Hand; Hares; Hu | 2019 |
A Child With Unilateral Conjunctivitis and Elevated Inflammatory Markers.
Topics: Anti-Bacterial Agents; Biomarkers; Blood Sedimentation; C-Reactive Protein; Child; Ciprofloxacin; Co | 2018 |
Clinical characteristics in a sentinel case as well as in a cluster of tularemia patients associated with grape harvest.
Topics: Adult; Animals; Child; Child, Preschool; Ciprofloxacin; Female; Humans; Male; Middle Aged; Tularemia | 2019 |
Unilateral acute dacryocystitis associated with oculoglandular tularemia: a case report.
Topics: Acute Disease; Adult; Amikacin; Anti-Bacterial Agents; Antibodies, Bacterial; Ciprofloxacin; Clavula | 2013 |
[Fever and lymphadenopathy. Report of 4 cases of tularemia].
Topics: Aged; Anti-Infective Agents; Child; Ciprofloxacin; Female; Fever; Gentamicins; Humans; Lymphatic Dis | 2013 |
Liposome encapsulation of ciprofloxacin improves protection against highly virulent Francisella tularensis strain Schu S4.
Topics: Administration, Inhalation; Administration, Intranasal; Aerosols; Animals; Bacterial Vaccines; Biolo | 2014 |
Pneumonic tularemia presenting with a vesicular eruption.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Female; Francisella tularensis; Humans; Pneumonia, Bact | 2015 |
CLINICAL PROBLEM-SOLVING. Back to Nature.
Topics: Adult; Anorexia; Anti-Bacterial Agents; Ciprofloxacin; Colitis, Ulcerative; Diagnosis, Differential; | 2015 |
A 65-Year-Old Groundskeeper With High Fever, Pulmonary Nodules, and Thoracic Lymphadenopathy.
Topics: Aged; Anti-Bacterial Agents; Ciprofloxacin; Diagnosis, Differential; Francisella tularensis; Humans; | 2016 |
[Rabbit fever--a neck tumor].
Topics: Animal Husbandry; Animals; Anti-Infective Agents; Ciprofloxacin; Diagnosis, Differential; Francisell | 2010 |
Tularaemia in Minnesota: case report and brief epidemiology.
Topics: Animals; Autopsy; Bites and Stings; Cats; Ciprofloxacin; Contact Tracing; Doxycycline; Female; Franc | 2010 |
Tularemia presenting as a cervical abscess.
Topics: Abscess; Adult; Anti-Infective Agents; Ciprofloxacin; Contrast Media; Diagnosis, Differential; Human | 2010 |
[Streptococcus pneumonia infection and positive blood culture with Francisella tularensis, in a renal transplant recipient].
Topics: Aged; Anti-Bacterial Agents; Bacteriological Techniques; Blood; Ceftriaxone; Ciprofloxacin; Drug The | 2011 |
Cavitary pneumonia and skin lesions.
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Ciprofloxacin; Female; H | 2012 |
Consequences of delayed ciprofloxacin and doxycycline treatment regimens against Francisella tularensis airway infection.
Topics: Animals; Ciprofloxacin; Doxycycline; Female; Francisella tularensis; Mice; Mice, Inbred BALB C; Tula | 2012 |
Clinical recognition and management of tularemia in Missouri: a retrospective records review of 121 cases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Arachnid Vectors; Child; | 2012 |
Infectious nontuberculous serpiginous choroiditis.
Topics: Adult; Anti-Infective Agents; Antibodies, Bacterial; Aza Compounds; Bartonella henselae; Cat-Scratch | 2012 |
Tularemia in central Anatolia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Biopsy, Fine-Nee | 2013 |
[In Vitro Activity of Tigecycline Against Francisella tularensis Subsp. holarctica in Comparison with Doxycycline, Ciprofloxacin and Aminoglycosides].
Topics: Aminoglycosides; Anti-Bacterial Agents; Ciprofloxacin; Doxycycline; Francisella tularensis; Humans; | 2013 |
Tularemia of the head and neck: a possible sign of bioterrorism.
Topics: Adult; Anti-Infective Agents; Bioterrorism; Ciprofloxacin; Francisella tularensis; Humans; Male; Nec | 2003 |
Liposome delivery of ciprofloxacin against intracellular Francisella tularensis infection.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Delayed-Action Preparations; Disease Models, Animal; | 2003 |
Tularemia after a dormouse bite in Switzerland.
Topics: Animals; Anti-Bacterial Agents; Bites and Stings; Ciprofloxacin; Humans; Male; Middle Aged; Myoxidae | 2005 |
In vivo efficacy of fluoroquinolones against systemic tularaemia infection in mice.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Colony Count, Mi | 2005 |
Treatment of murine pneumonic Francisella tularensis infection with gatifloxacin, moxifloxacin or ciprofloxacin.
Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Female; Fluoroquinolones; Gatifloxacin | 2006 |
Tularemia, a reemerging disease in northwest Turkey: epidemiological investigation and evaluation of treatment responses.
Topics: Adolescent; Adult; Aged; Agglutination Tests; Child; Ciprofloxacin; Disease Outbreaks; Doxycycline; | 2006 |
Two unusual glandular presentations of tick-borne tularemia.
Topics: Animals; Bites and Stings; Ciprofloxacin; Combined Modality Therapy; Contraindications; Doxycycline; | 2008 |
Liposome-encapsulated ciprofloxacin is effective in the protection and treatment of BALB/c mice against Francisella tularensis.
Topics: Animals; Ciprofloxacin; Drug Compounding; Female; Liposomes; Mice; Mice, Inbred BALB C; Tularemia | 1993 |
Aerosol delivery of liposome-encapsulated ciprofloxacin: aerosol characterization and efficacy against Francisella tularensis infection in mice.
Topics: Administration, Inhalation; Aerosols; Animals; Anti-Infective Agents; Ciprofloxacin; Drug Carriers; | 1997 |
Acute glaucoma and acute corneal oedema in association with tularemia.
Topics: Acute Disease; Adrenergic beta-Antagonists; Anti-Infective Agents; Ciprofloxacin; Corneal Edema; Eye | 1997 |
The efficacy of ciprofloxacin and doxycycline against experimental tularaemia.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Ciprofloxacin; Diseas | 1998 |
[Treatment of tularemia in children].
Topics: Age Factors; Anti-Bacterial Agents; Anti-Infective Agents; Child; Child, Preschool; Ciprofloxacin; H | 1998 |
Tularemia--an unusual cause of a solitary pulmonary nodule in the post-transplant setting.
Topics: Anti-Infective Agents; Ciprofloxacin; Francisella tularensis; Hematopoietic Stem Cell Transplantatio | 1999 |
[Meningitis caused by Francisella Tularensis].
Topics: Ciprofloxacin; Drug Therapy, Combination; Female; Fever; Follow-Up Studies; Francisella tularensis; | 1996 |
Ciprofloxacin for treatment of tularemia in children.
Topics: Administration, Oral; Anti-Infective Agents; Child; Child, Preschool; Ciprofloxacin; Female; Francis | 2000 |
Cat-bite tularemia in a seventeen-year-old girl treated with ciprofloxacin.
Topics: Adolescent; Animals; Anti-Infective Agents; Bites and Stings; Cats; Ciprofloxacin; Female; Humans; T | 2000 |
[The chemotherapeutic efficacy of ciprofloxacin and lomefloxacin in the inhalation method of infecting white mice with tularemia].
Topics: Aerosols; Animals; Anti-Infective Agents; Ciprofloxacin; Disease Models, Animal; Drug Evaluation, Pr | 2000 |
Treatment of tularemia with ciprofloxacin.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Female; Francisella tularensis | 2000 |
Ciprofloxacin for treatment of tularemia.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Humans; Middle Aged; Treatment | 2001 |
Tularemia of the middle ear.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Local; Anti-Inflammatory Agents | 2002 |
Treatment of tularemia with ciprofloxacin.
Topics: Adult; Amoxicillin; Animals; Cats; Ciprofloxacin; Doxycycline; Francisella tularensis; Humans; Male; | 1992 |
In vitro susceptibility of Francisella tularensis to fluoroquinolones and treatment of tularemia with norfloxacin and ciprofloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Francisella tularensis; Microbial Sensitivity Tests; Norfloxac | 1991 |